Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Jul 26;24(12):e26–e30. doi: 10.1016/j.bbmt.2018.07.032

Table 3:

Transplant Outcomes by Patient.

Pt Neutrophil engraftment (day) Red cell engraftment (day) Platelet engraftment (Day) Day 30 T Cell (% donor) Day 30 Myeloid (% donor) GVHD Viral infections Bacterial Infections Post Granulocyte Clone (%)
1 19 16 28 100 100 None None None 0
2 24 20 31 100 100 None None None 0
3 20 27 33 >95 >95 None CMV, BK Enteroccus in the urine without pyyruia 0
4 41 115 190 22 100 None BK None 0
5 18 24 22 100 100 None CMV None 0
6 21 24 24 100 100 None None Enteroccus in the urine without pyyruia 0
7 19 19 23 100 100 None HHV6, BK C difficile in stool 0
8 14 14 18 100 100 None None Sinusitis without organism identified 0